Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. (000048112)

On this page

Documents
Profile details
Company identification
Reporting issuer details
Formation details
Financial year end
Size and industry classification
Securities
Associated entities
Previous issuers

Profile details

Profile number
000048112
Status
Public
Full legal company name in English
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp.
Full legal company name in French
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp.
Effective from date
06 May 2019
Previous name in English
VINCERO CAPITAL CORP.
Previous name in French
VINCERO CAPITAL CORP.
Effective up to date
01 Jan 1500
Previous name in English
RAKOVINA THERAPEUTICS INC. (FORMERLY, VINCERO CAPITAL CORP.)
Previous name in French
RAKOVINA THERAPEUTICS INC. (FORMERLY, VINCERO CAPITAL CORP.)
Effective up to date
06 May 2019
This company is an Investment Fund Manager
No
This company is an Underwriter
No
Head office address
Suite 720, 999 West Broadway, Vancouver, British Columbia, V5Z 1K5, Canada
Mailing address
Same as head office
Fax number
+1 (604) 980-6264

Company identification

Legal Entity Identifier (LEI)
 

Reporting issuer details

Reporting issuer
Yes
Over-The-Counter (OTC) issuer
No
Exchangeable Security or Credit Support issuer
Not applicable
Capital Pool Company (CPC)
No
Eligible for short form prospectus
Yes
Principal jurisdiction
British Columbia
Reporting jurisdiction(s)
Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Northwest Territories, Nova Scotia, Nunavut, Ontario, Prince Edward Island, Québec, Saskatchewan, Yukon

Formation details

Date of formation
06 May 2019
Manner of formation
Corporation
Jurisdiction where formed
Canada, British Columbia
Chief Executive Officer (CEO) - full legal name
BACHA, Jeffrey
Chief Financial Officer (CFO) - full legal name
KIDECKEL, David

Financial year end

Type of financial year end
Fixed year end
Financial year end
December 31

Size and industry classification

NAICS
541710 - Research and development in the physical, engineering and life sciences
Size of issuer (assets)
$5 million to under $25 million

Securities

Listed on an exchange or other market place
Yes
Exchange or market place
TSX Venture (TSXV) - RKV
CUSIP
75103L
ISIN
CA75103L1013

Associated entities

Transfer agent or registrar
Odyssey Trust Company
350-409 Granville St., Vancouver, British Columbia, V6C 1T2, Canada
F: +1 (800) 517-4553
Auditor
Davidson & Company LLP / Davidson & Company LLP
Address
1200 -609 Granville St., Vancouver, British Columbia, V7Y 1G6, Canada
F: +1 (604) 687-6172

Previous issuers

Previous issuer(s)
No
Unsaved changes will be lost. Are you sure you wish to exit?
Unsaved changes will be lost. Are you sure you want to cancel?
???label.checkSubmitMsg???